CRISPR Therapeutics AG (CRSP) William Blair’s 45th Annual Growth Stock Conference (Transcript)

CRISPR Therapeutics AG (NASDAQ:CRSP) William Blair’s 45th Annual Growth Stock Conference June 3, 2025 12:20 PM ET

Company Participants

Raju Prasad – Chief Financial Officer

Conference Call Participants

Sami Corwin – William Blair

Sami Corwin

Hi, everyone. We’re going to get started. I’m Sami Corwin, the biotech equity research analyst covering CRISPR at William Blair. Before we get started, I would like to direct everyone to williamblair.com for a full list of disclosures.

I’m very pleased to introduce CRISPR’s Chief Financial Officer, Raju Prasad, who’s going to provide an overview of the Company. And then, if we have any remaining time, we can take some questions. Raj, thank you.

Raju Prasad

Great. Thanks, Sami. And it’s great to be back, and thanks to Sami and the rest of the team at William Blair, for having us again. At CRISPR Therapeutics, we are focused on one goal and that’s to create transformative gene-based medicines for serious diseases. Those are forward-looking statements.

Today, I think we’ve already done that once. We have an improved therapy in CASGEVY, where our partner Vertex is leading commercialization. What we’re doing with the technology, the gene-editing technology, now is trying to get our second, third, fourth, fifth products up and going. And so, we’ve got several clinical trials ongoing that’ll have readouts over the next 6 to 12 months, that’ll really determine the future strategic direction of the Company.

And beyond that, we’ve got several preclinical programs, again, having this expansive platform technology. We have the ability to apply it to multiple diseases. And based on resource allocation, obviously, can’t do everything, but we have the ability to really exponentially grow our pipeline and our offerings in the much longer timeframe as we look to become a sustainable biotech.

Currently, our vision for how we can prosecute